Fundraising Fox
Advanced BioDesign
1 known investors
Find your way into Advanced BioDesign
Sign up to find every way you can get introduced to Advanced BioDesign
- Your email: who you already know at Advanced BioDesign, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Advanced BioDesign team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Advanced BioDesign is a clinical-stage French biotechnology company developing small-molecule ALDH1 enzyme inhibitors to overcome drug resistance in chemotherapy-resistant cancers. Its work targets oncology indications such as acute myeloid leukemia, non-small cell lung cancer, and melanoma, alongside a companion diagnostic to stratify patients.
Investors · 1
In the news
Frequently asked questions
- What does Advanced BioDesign do?
- Advanced BioDesign is a clinical-stage French biotechnology company developing small-molecule ALDH1 enzyme inhibitors to overcome drug resistance in chemotherapy-resistant cancers. Its work targets oncology indications such as acute myeloid leukemia, non-small cell lung cancer, and melanoma, alongside a companion diagnostic to stratify patients.
- Who are Advanced BioDesign's investors?
- Advanced BioDesign's investors include Xerys.